跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
DANYELZA CONCENTRATE FOR SOLUTION FOR INFUSION 40MG/10ML - PPB Drug Approval Details
Approvals
/
PPB
/
DANYELZA CONCENTRATE FOR SOLUTION FOR INFUSION 40MG/10ML
Approved
STANDARD
DANYELZA CONCENTRATE FOR SOLUTION FOR INFUSION 40MG/10ML
SCICLONE PHARMACEUTICALS INTERNATIONAL LTD
🇰🇪 Pharmacy and Poisons Board
Approval Date
May 30, 2025
Approval ID
d5cc85a9d721b150
Company
SCICLONE PHARMACEUTICALS INTERNATIONAL LTD
Type
Standard
Approval Details
Approval Id
d5cc85a9d721b150
Product Name
DANYELZA CONCENTRATE FOR SOLUTION FOR INFUSION 40MG/10ML
Drug Hk Name
DANYELZA CONCENTRATE FOR SOLUTION FOR INFUSION 40MG/10ML
Registration Code
HK-68305
Company Name
SCICLONE PHARMACEUTICALS INTERNATIONAL LTD
Company Detail Path
/organization/sciclone-pharmaceuticals-international-ltd
Registration Category
Part 1, Schedule 1 & Schedule 3 Poison
Sale Requirement
Prescription only Medicines
Registration Date
2024-07-16
Company Address
UNIT 3, 14/F, CHEUNG FUNG INDUSTRIAL BUILDING, 23-39, PAK TIN PAR STREET, TSUEN WAN, NEW TERRITORIES
Active Ingredients
Approved
Quick Info
Agency
PPB
Country
🇰🇪
Approval Date
May 30, 2025
Approval ID
d5cc85a9d721b150
Type
Standard
Back to PPB Approvals